Evidence map›Paper›PMID 34199093›Full record

ArticleBrain sciences2021

Single Word Intelligibility of Individuals with Parkinson's Disease in Noise: Pre-Specified Secondary Outcome Variables from a Randomized Control Trial (RCT) Comparing Two Intensive Speech Treatments (LSVT LOUD vs. LSVT ARTIC).

Geralyn Schulz, Angela Halpern, Jennifer Spielman, Lorraine Ramig, Ira Panzer, Alan Sharpley, Katherine Freeman

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Geralyn SchulzDepartment of Speech, Language, and Hearing Sciences, College of Arts and Sciences, George Washington University, Washington, DC 20052, USA.
Angela HalpernLSVT Global, Inc., Tucson, AZ 85705, USA.
Jennifer SpielmanLSVT Global, Inc., Tucson, AZ 85705, USA.
Lorraine RamigLSVT Global, Inc., Tucson, AZ 85705, USA.
Ira PanzerDynastat, Inc., Austin, TX 78731, USA.
Alan SharpleyDynastat, Inc., Austin, TX 78731, USA.
Katherine FreemanDepartment of Biomedical Sciences, Charles E. Schmidt College, Florida Atlantic University, Boca Raton, FL 33431, USA.
Denver Center for the Performing Arts · USFlorida Atlantic University · USGeorge Washington University · US

Funding

EFFICACY OF VOICE TREATMENT FOR PARKINSONS DISEASER01DC001150 · NIDCD · UNIVERSITY OF COLORADO AT BOULDER · PI RAMIG, LORRAINE O. · 1990 to 2011
$5.8M
NIDCD NIH HHS R01 DC001150NIH HHS R01 DC01150
6 · The paper itself

Abstract

The majority of people with Parkinson's disease (PD) experience both prosodic changes (reduced vocal volume, reduced pitch range) and articulatory changes (imprecise articulation) that often limit speech intelligibility and may contribute to significant declines in quality of life. We conducted a randomized control trial comparing two intensive treatments, voice (LSVT LOUD) or articulation (LSVT ARTIC) to assess single word intelligibility in the presence of background noise (babble and mall). Participants (64 PD and 20 Healthy) read words from the diagnostic rhyme test (DRT), an ANSI Standard for measuring intelligibility of speech, before and after one month (treatment or no treatment). Teams of trained listeners blindly rated the data. Speech intelligibility of words in the presence of both noise conditions improved in PD participants who had LSVT LOUD compared to the groups that had LSVT ARTIC or no treatment. Intensive speech treatment targeting prominent prosodic variables in LSVT LOUD had a positive effect on speech intelligibility at the single word level in PD.

Indexed as

dysarthriaLSVT LOUDmotor speech disordersParkinson’s diseaseprosody treatment

Identifiers

PMID34199093
PMCPMC8301858
OpenAlexW3174982379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.